DOI: https://doi.org/10.14710/jbtr.v6i2.6299

A Rare Case of 18-year-old female with Primary Sclerosing Cholangitis, Mixed Connective Tissue Disease, Short Stature

Diponegoro University, Indonesia

Received: 16 Dec 2019; Revised: 18 Aug 2020; Accepted: 16 Aug 2020; Available online: 31 Aug 2020; Published: 31 Aug 2020.
Open Access Copyright (c) 2020 Journal of Biomedicine and Translational Research

Citation Format:
Abstract

Background: Primary sclerosing cholangitis (PSC) is a rare chronic immune-mediated liver disease affecting intra and extrahepatic bile ducts, in which inflammation and fibrosis are the main factors that lead to biliary stricture. The pathogenesis of this disease is still unclear. It happens approximately 0.5 to 1.3 cases per 100,000 person-years in Northern Europe. PSC is difficult to diagnose until complications arise. PSC can also be a manifestation of mixed connective tissue disease (MCTD) in the liver. A chronic immune disease that has occurred since childhood may result in delayed development and short stature. 

Case Presentation:   A 18-year-old female presented with icteric, anemia, short stature, and absence of menstruation. Laboratory and radiological findings suggested obstruction of intra and extrahepatic biliary duct (conjugated bilirubin 11,80 mg/dL), severe anemia, normal sex hormone levels, increased RNP/SM antibodies. Histopathology showed liver cirrhosis suggestive for primary sclerosing cholangitis. The patient then was given biliary stenting, transfusion of packed red cell, immunosuppresive, corticosteroid, ursodeoxycholic acid. Within a year of treatment, there was a significant decrease of direct bilirubin and improvement in symptoms.

Conclusion: Patient with PSC, MCTD, and short stature is a very rare case. This is the first case that has been found in dr. Kariadi Hospital, Semarang. It has high mortality rate and difficult to diagnose and treat. According to multiple guidelines, this patient should have liver transplantation , but in this case, biliary stenting and oral treatments have resulted in an excellent outcome.

Fulltext View|Download
Keywords: Primary sclerosing cholangitis; MCTD; short stature
Funding: Diponegoro University

Article Metrics:

Article Info
Section: Case Reports
Language : EN
Recent articles
Optimizing Real-Time PCR methods for detection of ssaN gene Salmonella enterica subsp.enterica in the blood specimen In silico Identification of Characteristics Spike Glycoprotein of SARS-CoV-2 in the Development Novel Candidates for COVID-19 Infectious Diseases Effect of Metformin on Bcl-2/Bax Expression Ratio and Endometrial Implants: A Mouse Model in Endometriosis Study A Rare Case of 18-year-old female with Primary Sclerosing Cholangitis, Mixed Connective Tissue Disease, Short Stature Knowing When and How to Fight: COVID-19 Between Viral Clearance and Immune Tolerance More recent articles
  1. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010 Feb;51(2):660-78
  2. Fousekis FS, Theopistos VI, Mitselos IV, Skamnelos A, Kavvadias A, Katsanos KH, Christodoulou DK. Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Journal of clinical medicine research. 2019 Feb;11(2):81
  3. Tabibian JH, Ali AH, Lindor KD. Primary sclerosing cholangitis, Part 1: Epidemiology, etiopathogenesis, clinical features, and treatment. Gastroenterology & hepatology. 2018 May;14(5):293
  4. Grutters JC, Lammers JW. Connective Tissue Diseases. InClinical Respiratory Medicine 2012 Jan 1 (pp. 653-666). WB Saunders
  5. De Santis M, Crotti C, Selmi C. Liver abnormalities in connective tissue diseases. Best Practice & Research Clinical Gastroenterology. 2013 Aug 1;27(4):543-51
  6. Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology. 2013 Sep 1;145(3):521-36
  7. Sirpal S, Chandok N. Primary sclerosing cholangitis: diagnostic and management challenges. Clinical and experimental gastroenterology. 2017;10:265
  8. Virani S, Akers A, Stephenson K, Smith S, Kennedy L, Alpini G, Francis H. Comprehensive Review of Molecular Mechanisms during Cholestatic Liver Injury and Cholangiocarcinoma. Journal of liver. 2018;7(3)
  9. Abu-Wasel B, Keough V, Renfrew PD, Molinari M. Biliary stent therapy for dominant strictures in patients affected by primary sclerosing cholangitis. Pathobiology. 2013;80(4):182-93
  10. Goode EC, Rushbrook SM. A review of the medical treatment of primary sclerosing cholangitis in the 21st century. Therapeutic advances in chronic disease. 2016 Jan;7(1):68-85
  11. Chapman MH, Thorburn D, Hirschfield GM, Webster GG, Rushbrook SM, Alexander G, Collier J, Dyson JK, Jones DE, Patanwala I, Thain C. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut. 2019 Jun 1:gutjnl-2018
  12. Fung BM, Tabibian JH. Biliary endoscopy in the management of primary sclerosing cholangitis and its complications. Liver research. 2019 Apr 3
  13. Chentoufi AA, Serov YA, Alazmi M, Baba K. Immune components of liver damage associated with connective tissue diseases. Journal of clinical and translational hepatology. 2014 Mar;2(1):37
  14. Rogol A D. Causes of short stature. In: Snyder PJ, Geffner ME, editors. UpToDate [Internet]. Waltham (MA): UpToDate Inc; 2019 [cited 2019 Jul 14]. Available from: https://www.uptodate.com/contents/causes-of-short-stature/contributor-disclosure

Last update:

No citation recorded.

Last update:

No citation recorded.